(19)
(11) EP 1 606 277 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.10.2008 Bulletin 2008/42

(45) Mention of the grant of the patent:
14.05.2008 Bulletin 2008/20

(21) Application number: 04717578.1

(22) Date of filing: 05.03.2004
(51) International Patent Classification (IPC): 
C07D 401/06(2006.01)
C07D 413/14(2006.01)
A61K 31/4178(2006.01)
A61P 25/00(2006.01)
 C07D 401/14(2006.01)
C07D 417/14(2006.01)
A61K 31/4439(2006.01)
A61P 25/22(2006.01)
(86) International application number:
PCT/EP2004/002276
(87) International publication number:
WO 2004/080998 (23.09.2004 Gazette 2004/39)

(54)

IMIDAZOL-4-YL-ETHYNYL-PYRIDINE DERIVATIVES

IMIDAZOL-4-YL-ETHYNYL-PYRIDIN-DERIVATE

DERIVES DE L'IMIDAZOL-4-YL-ETHYNYL-PYRIDINE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
LT LV

(30) Priority: 10.03.2003 EP 03004952

(43) Date of publication of application:
21.12.2005 Bulletin 2005/51

(73) Proprietor: F. Hoffmann-La Roche AG
4070 Basel (CH)

(72) Inventors:
  • BUETTELMANN, Bernd
    79650 Schopfheim (DE)
  • CECCARELLI, Simona, Maria
    CH-4057 Basel (CH)
  • JAESCHKE, Georg
    CH-4051 Basle (CH)
  • KOLCZEWSKI, Sabine
    79618 Rheinfelden (DE)
  • PORTER, Richard, Hugh, Phillip
    CH-4153 Reinach (CH)
  • VIEIRA, Eric
    CH-4402 Frenkendorf (CH)

(74) Representative: Braun, Axel 
F.Hoffmann-La Roche AG Patent Department (PLP), 124 Grenzacherstrasse
4070 Basel
4070 Basel (CH)


(56) References cited: : 
EP-A- 0 304 910
   
  • ARENA F ET AL: "STRUCTURE-ACTIVITY RELATIONSHIPS IN REACTIVATORS OF ORGANOPHOSPHORUS-INHIBITED ACETYLCHOLINESTERASE.10. HYDROXYIMINOMETHYLARYLETHENYLPYRIDINE METHIODIDES" JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 18, no. 11, 1975, pages 1147-1150, XP001005697 ISSN: 0022-2623
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).